Dr. Kenneth Hyunsoo Park, MD, MS

Dr. Park practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Park's NPI, 1245522739, was assigned on May 3, 2011. Dr. Park graduated from New York University School of Medicine in 2011. Dr. Park holds California license A149954.

Dr. Park's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Park's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Park is also affiliated with Community Memorial Hospital - Ventura. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Park practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Park's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Park is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Park's licenses on file in 2 states: California and New York.

Dmand AI lists acid reflux, colonoscopy, esophagus, stomach, or upper small intestine surgery, gastrointestinal bleeding, gastrointestinal inflammation, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Park treats.

CMS data shows 753 Medicare services from Dr. Park across 21 procedure codes in 2024, for 347 Medicare patients. Medicare paid $95,982 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 347 Medicare patients who saw Dr. Park in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Park's median patient age at 72, with 48% women.

In 2024, Dr. Park wrote 271 Medicare Part D claims for 151 patients. 94% of them were for generic drugs. CMS names the drug for 224 of them, across 6 drugs with 11 or more claims each, at $2,392 in total drug cost. In 2023, CMS named 239 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Park for performance year 2024, reported as part of a group. Dr. Park accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Park as offering telehealth. CMS counts 521 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Park, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Park, published from 2018 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Electronic Nicotine Delivery Systems and Endoscopic Mucosal Resection. Dr. Park has published most often in Gastrointest Endosc. Dr. Park's most frequent co-authors are Srinivas Gaddam, MD, Laith Hikmet Jamil, MD and Simon K. Lo, MD.

CMS Open Payments shows 95 general payments to Dr. Park from 10 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Boston Scientific Corporation paid the most, $39,459.

Dr. Park graduated from New York University School of Medicine in 2011.

Dr. Park is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.